slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 77,971-78,000
Pages 3,679
Rows per page 30
Component
77,971-78,000 of 110,355
06
Uses a waterfall-bridge style to illustrate revenue growth drivers and headwinds.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
07
The slide uses a structured grid to map high-level strategic goals to specific clinical assets.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
12
The slide uses a three-row structure to categorize clinical and technological progress.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
16
The slide uses a process flow diagram to explain the computational pathology workflow.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
17
Includes a Kaplan-Meier survival curve, a bar chart of prevalence by histology, and a Venn-style diagram illustrating the patient population selection process.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
19
The slide uses a matrix-like layout to map clinical trials to patient segments. The right-hand side provides a strategic summary of the trial program's design principles.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
Includes references to clinical trials (CheckMate 274, AMBASSADOR, NIAGARA) and drug (Imfinzi).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
23
Clinical trial design flow chart.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
28
Includes 'No. of patients at risk' table and statistical summary table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
29
Forest plot showing hazard ratios with 95% confidence intervals for multiple clinical subgroups.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
31
The chart uses a diverging bar structure to compare two treatment arms side-by-side.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
34
The slide uses a market segmentation approach to map clinical trials (NIAGARA, POTOMAC, VOLGA, NILE) to patient populations (NMIBC, MIBC, 1L mUC).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
38
The chart is a stacked area chart showing market growth by target segment (HER2, TROP2, Nectin4, etc.).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
39
The slide uses a horizontal bar chart to represent clinical development stages for six different ADC assets.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
The slide compares plasma concentration over time for two different ADCs, showing the stability of the ADC vs the mAb and the low levels of free payload.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
41
Waterfall plot shows best change in target lesion size; includes CA-125 response markers.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
42
Waterfall plot shows RECIST v1.1 response criteria. Includes legend for dose levels and callout boxes for clinical outcomes.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
45
WCLC conference presentation slide. Includes waterfall plot and summary table of ORR and treatment continuation.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
46
Spider plot (swimmer plot variant) showing individual patient response trajectories.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
47
Waterfall plot shows tumor shrinkage; includes key clinical metrics (ORR, mPFS) and safety/future trial status.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
49
The chart uses a bridge/waterfall structure to show revenue growth drivers.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
53
The slide uses a grid layout to categorize clinical trials by disease stage and patient population, highlighting established standards of care (SoC) with hatched patterns.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
54
The slide uses a matrix structure to categorize clinical trials (e.g., DESTINY-Breast, TROPION-Breast, CAPItello) by patient population and treatment line.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
07
The slide uses a split-screen layout to contrast partnership-based revenue with internal pipeline development.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
14
Includes two process diagrams illustrating the Benevolent Platform's role and the experimental validation process.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
15
The slide uses a table to demonstrate market validation for early-stage IBD assets.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Market Size1 hit
16
The slide uses a causal chain logic to connect market deal activity and clinical unmet needs to the value proposition of the drug.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Loop · Why Now1 hit
24
The slide uses a split-screen approach to contrast two distinct value drivers: cost reduction and success rate improvement.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
25
The slide uses a table format to demonstrate differentiation and market potential for five specific pipeline assets.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
11
Includes footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Action1 hit